JP2020536862A5 - - Google Patents

Download PDF

Info

Publication number
JP2020536862A5
JP2020536862A5 JP2020519028A JP2020519028A JP2020536862A5 JP 2020536862 A5 JP2020536862 A5 JP 2020536862A5 JP 2020519028 A JP2020519028 A JP 2020519028A JP 2020519028 A JP2020519028 A JP 2020519028A JP 2020536862 A5 JP2020536862 A5 JP 2020536862A5
Authority
JP
Japan
Prior art keywords
infection
vaginal
compound
infections
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020519028A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020536862A (ja
JP7424636B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2018/077129 external-priority patent/WO2019068862A1/en
Publication of JP2020536862A publication Critical patent/JP2020536862A/ja
Publication of JP2020536862A5 publication Critical patent/JP2020536862A5/ja
Application granted granted Critical
Publication of JP7424636B2 publication Critical patent/JP7424636B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020519028A 2017-10-06 2018-10-05 微生物感染症の治療および/または予防用グルコン酸誘導体 Active JP7424636B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17195192 2017-10-06
EP17195192.4 2017-10-06
PCT/EP2018/077129 WO2019068862A1 (en) 2017-10-06 2018-10-05 GLUCONIC ACID DERIVATIVES FOR USE IN THE TREATMENT AND / OR PREVENTION OF MICROBIAL INFECTIONS

Publications (3)

Publication Number Publication Date
JP2020536862A JP2020536862A (ja) 2020-12-17
JP2020536862A5 true JP2020536862A5 (enExample) 2021-11-11
JP7424636B2 JP7424636B2 (ja) 2024-01-30

Family

ID=60185986

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020519028A Active JP7424636B2 (ja) 2017-10-06 2018-10-05 微生物感染症の治療および/または予防用グルコン酸誘導体

Country Status (21)

Country Link
US (3) US11612584B2 (enExample)
EP (1) EP3691625B1 (enExample)
JP (1) JP7424636B2 (enExample)
KR (1) KR102650182B1 (enExample)
CN (1) CN111182895B (enExample)
AU (1) AU2018346361B2 (enExample)
BR (1) BR112020006931A2 (enExample)
CA (1) CA3078451A1 (enExample)
CL (1) CL2020000859A1 (enExample)
EA (1) EA202090750A1 (enExample)
ES (1) ES3017694T3 (enExample)
HU (1) HUE070746T2 (enExample)
IL (1) IL273297B2 (enExample)
MX (1) MX2020003660A (enExample)
MY (1) MY205944A (enExample)
PH (1) PH12020550222A1 (enExample)
PL (1) PL3691625T3 (enExample)
SG (1) SG11202002494WA (enExample)
UA (1) UA126590C2 (enExample)
WO (1) WO2019068862A1 (enExample)
ZA (1) ZA202001605B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3017694T3 (en) 2017-10-06 2025-05-13 Gedea Biotech Ab Gluconic acid derivatives for use in the treatment and/or prevention of microbial infections
MY208388A (en) 2019-04-05 2025-05-06 Gedea Biotech Ab Vaginal tablet formulation
CN114751878B (zh) * 2022-03-29 2023-06-16 青岛农业大学 一种BcTol1基因靶向剂及其应用
WO2024261110A1 (en) * 2023-06-22 2024-12-26 Gedea Biotech Ab Compositions for promoting growth of lactobacillus crispatus

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1278868B1 (it) 1995-10-27 1997-11-28 Sanitaria Scaligera Spa Metodo per l'ottenimento di un materiale riassorbibile atto ad essere utilizzato come elemento di rivestimento per la prevenzione di
AUPP839499A0 (en) 1999-01-29 1999-02-25 Australian National University, The A method for controlling plant pathogens, and agents useful for same
JP3745612B2 (ja) 2000-10-31 2006-02-15 西川ゴム工業株式会社 ポリヒドロキシカルボン酸の製造方法
US20030017207A1 (en) 2001-05-01 2003-01-23 Lin Shun Y. Compositions and methods for treating vulvovaginitis and vaginosis
US20060172007A1 (en) * 2001-05-01 2006-08-03 Nawaz Ahmad Compositions and methods for reducing vaginal pH
US20060105008A1 (en) 2002-03-28 2006-05-18 Nawaz Ahmad Compositions and methods for reducing vaginal pH
CA2487270C (en) 2002-06-21 2010-10-26 The Procter & Gamble Company Antimicrobial compositions, products and methods employing same
US7569530B1 (en) 2003-06-20 2009-08-04 The Procter & Gamble Company Antimicrobial compositions, products and methods employing same
US7547454B2 (en) * 2002-11-07 2009-06-16 Shyam K Gupta Hydroxy acid complexes for antiaging and skin renovation
US20040126369A1 (en) * 2002-12-30 2004-07-01 Richard Payne Delivery of peroxide-generating enzymes to the vaginal tract
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US20050260243A1 (en) * 2004-04-26 2005-11-24 The Procter & Gamble Company Method of treating microbial plant diseases
US20050271711A1 (en) 2004-04-26 2005-12-08 The Procter & Gamble Company Therapeutic antimicrobial compositions and methods
AU2006209263A1 (en) 2005-09-12 2007-03-29 Mcneil-Ppc, Inc. Anhydrous composition containing an acid-acid buffer system
US20070059278A1 (en) 2005-09-12 2007-03-15 Nawaz Ahmad Anhydrous composition containing an acid-acid buffer system
US20080058421A1 (en) * 2006-09-05 2008-03-06 John Alex Lopes Compositions for cleaning and disinfecting nasal tract and sinus cavity
WO2008108834A2 (en) * 2006-11-09 2008-09-12 Northwestern University Inhibitors of the mevalonate pathway of streptococcus pneumoniae
JP2008283893A (ja) * 2007-05-16 2008-11-27 Sumitomo Chemical Co Ltd 家禽用コクシジウム感染抑制剤及びそれを用いたコクシジウム感染抑制方法
US20100285095A1 (en) * 2009-05-05 2010-11-11 Kimberly Ann Nemeth Hygiene Article Having Calcium Sugar Acid Salt
CN102070774B (zh) 2010-11-25 2012-08-22 华南师范大学 单糖或其糖醇与乳酸的共聚物的制备方法
MX2013012745A (es) 2011-05-02 2014-12-05 Aptalis Pharmatech Inc Composiciones en forma de comprmido de disolución rápida para administración vaginal.
MY172685A (en) 2013-11-08 2019-12-10 Suzhou Osel Bio Pharm Co Ltd A lactobacillus crispatus and application thereof
DK178786B1 (en) * 2015-03-11 2017-02-06 Dantrace-Danfeed Ivs Use of zinc and copper gluconate in the treatment of methicillin-resistant staphylococcus aureus
DK3439633T3 (da) * 2016-04-06 2021-12-20 Gedea Biotech Ab Glucono delta-lacton til behandling af vaginale svampeinfektioner
JP7219712B2 (ja) 2016-10-13 2023-02-08 キャタレント・ユーケー・スウィンドン・ザイディス・リミテッド 膣送達のための凍結乾燥医薬組成物
KR101841976B1 (ko) 2017-06-07 2018-05-14 조영진 식물 추출물을 포함하는 항진균 및 항균 조성물
ES3017694T3 (en) 2017-10-06 2025-05-13 Gedea Biotech Ab Gluconic acid derivatives for use in the treatment and/or prevention of microbial infections
MY208388A (en) 2019-04-05 2025-05-06 Gedea Biotech Ab Vaginal tablet formulation

Similar Documents

Publication Publication Date Title
JP2020536862A5 (enExample)
KR101518014B1 (ko) 부인과 질환의 치료에서의 락트산 올리고머의 용도
JPH09510468A (ja) 皮膚疾患の治療のための及びその皮膚の消毒のためのゲル
AU2005237546A1 (en) Therapeutic antimicrobial compositions and methods
JP2004508296A5 (enExample)
EP0862441A1 (en) Vaginal pharmaceutical compositions containing a peroxide source
JP2004525095A (ja) ポリスチレンスルホネートを用いた膣炎および/または細菌性膣症の予防、抑制、または治療方法
CN107151235A (zh) 噻二唑烷二酮基gsk3抑制剂在调节精子运动能力中的用途
US20050037033A1 (en) Microbicidal compositions and methods and use
CN111182895B (zh) 用于治疗和/或预防微生物感染的葡萄糖酸衍生物
CA2875784C (en) Pharmaceutical compositions containing oligomeric lactic acid
CN102824337B (zh) 一种治疗家畜子宫内膜炎的凝胶剂及其制备方法
JP2559735B2 (ja) 抗ー微生物組成物
CN113660928B (zh) 阴道片剂制剂
EP2544543A1 (en) Method of treatment
CN101172159A (zh) 酸性生物粘附热敏凝胶剂及其制法和用途
RU2751000C1 (ru) Формованный углеродный сорбент с гликолевой кислотой, способ его получения и способ лечения бактериального вагиноза
US12496288B2 (en) Vaginal tablet formulation
CN108126003A (zh) 一种女性阴部抑菌凝胶剂及其制备方法
CN106727275A (zh) 一种治疗阴道炎的栓剂组合物
RU2229878C1 (ru) Спермицидная активность этония
Powers ON DERMATOL, A PROPOSED SUBSTITUTE FOR 1ODOFORM--ITS USE IN SURGICAL PRACTICE